Roche (ROG) PT Set at CHF 226 by Kepler Capital Markets

Roche (VTX:ROG) received a CHF 226 target price from stock analysts at Kepler Capital Markets in a research note issued on Wednesday. The firm presently has a “neutral” rating on the healthcare company’s stock. Kepler Capital Markets’ price target points to a potential downside of 3.09% from the stock’s previous close.

A number of other analysts have also weighed in on ROG. Goldman Sachs Group set a CHF 325 price objective on shares of Roche and gave the company a “buy” rating in a research note on Thursday, September 21st. JPMorgan Chase & Co. restated a “buy” rating on shares of Roche in a research note on Thursday, January 11th. UBS Group restated a “neutral” rating on shares of Roche in a research note on Monday. Jefferies Group set a CHF 300 price objective on shares of Roche and gave the company a “buy” rating in a research note on Friday, January 5th. Finally, Deutsche Bank set a CHF 264 price objective on shares of Roche and gave the company a “neutral” rating in a research note on Monday. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and nine have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of CHF 258.95.

Roche (VTX:ROG) opened at CHF 233.20 on Wednesday. The stock has a market cap of $201,090.00 and a PE ratio of 20.73. Roche has a 12 month low of CHF 226.10 and a 12 month high of CHF 273.

WARNING: “Roche (ROG) PT Set at CHF 226 by Kepler Capital Markets” was first reported by BBNS and is the sole property of of BBNS. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://baseballnewssource.com/markets/roche-rog-pt-set-at-chf-226-by-kepler-capital-markets/1845791.html.

Roche Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche (VTX:ROG)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped


Leave a Reply

 
© 2006-2018 BBNS.